Literature DB >> 1945847

The peculiar binding properties of 4'-deoxy,4'-iododoxorubicin to isolated DNA and 175 bp nucleosomes.

C Cera1, M Palumbo.   

Abstract

The thermodynamic parameters governing the interaction of 4'-deoxy,4'-iododoxorubicin (4'-IAM) to double stranded DNA or 175 bp nucleosomes have been evaluated at different ionic strength and temperature conditions by means of fluorescence techniques. The iodo-anthracycline exhibits quite different characteristics from the parent compounds adriamycin (AM) and daunomycin (DM) and other second generation derivatives. In fact, the contribution of electrostatic interactions to the total free energy of binding is rather poor and the changes in enthalpy, usually high and negative, are low and eventually positive. Unlike other members of its family, 4'-IAM exhibits preference for the nucleosomal structure. In addition, its binding to isolated DNA is remarkably cooperative. Circular dichroism studies show changes in the geometry of the intercalation complex when the drug binds to nucleosomes. The possibility for the iodo-sugar moiety to act as an alkylating or free-radical producing species was also considered as an alternative mechanism of action. However, no evidence was obtained to support these hypotheses. Thus the major differences observed in DNA-binding in comparison to parent anthracyclines appear to be mostly related to the lower pKa and higher lipophilicity exhibited by 4'-IAM.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1945847      PMCID: PMC328979          DOI: 10.1093/nar/19.20.5707

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  25 in total

1.  Theoretical aspects of DNA-protein interactions: co-operative and non-co-operative binding of large ligands to a one-dimensional homogeneous lattice.

Authors:  J D McGhee; P H von Hippel
Journal:  J Mol Biol       Date:  1974-06-25       Impact factor: 5.469

Review 2.  On the mechanism of reductive activation in the mode of action of some anticancer drugs.

Authors:  V Favaudon
Journal:  Biochimie       Date:  1982-07       Impact factor: 4.079

Review 3.  Antitumor anthracyclines: recent developments.

Authors:  F Arcamone
Journal:  Med Res Rev       Date:  1984 Apr-Jun       Impact factor: 12.944

Review 4.  The anthracycline antineoplastic drugs.

Authors:  R C Young; R F Ozols; C E Myers
Journal:  N Engl J Med       Date:  1981-07-16       Impact factor: 91.245

5.  Mechanism of the inhibition of calf thymus DNA polymerases alpha and beta by daunomycin and adriamycin.

Authors:  M Tanaka; S Yoshida
Journal:  J Biochem       Date:  1980-03       Impact factor: 3.387

6.  Pentalysine-deoxyribonucleic acid interactions: a model for the general effects of ion concentrations on the interactions of proteins with nucleic acids.

Authors:  T M Lohman; P L deHaseth; M T Record
Journal:  Biochemistry       Date:  1980-07-22       Impact factor: 3.162

7.  Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicin.

Authors:  B Barbieri; F C Giuliani; T Bordoni; A M Casazza; C Geroni; O Bellini; A Suarato; B Gioia; S Penco; F Arcamone
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

8.  Binding of daunomycin to calf thymus nucleosomes.

Authors:  J B Chaires; N Dattagupta; D M Crothers
Journal:  Biochemistry       Date:  1983-01-18       Impact factor: 3.162

9.  Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-A resolution.

Authors:  A H Wang; G Ughetto; G J Quigley; A Rich
Journal:  Biochemistry       Date:  1987-02-24       Impact factor: 3.162

10.  Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG).

Authors:  G J Quigley; A H Wang; G Ughetto; G van der Marel; J H van Boom; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  1 in total

1.  Molecular structure of the halogenated anti-cancer drug iododoxorubicin complexed with d(TGTACA) and d(CGATCG).

Authors:  I Berger; L Su; J R Spitzner; C Kang; T G Burke; A Rich
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.